Waters Co. (NYSE:WAT) Shares Purchased by Epoch Investment Partners Inc.

Epoch Investment Partners Inc. increased its position in shares of Waters Co. (NYSE:WATFree Report) by 148.6% in the fourth quarter, HoldingsChannel reports. The firm owned 259,691 shares of the medical instruments supplier’s stock after acquiring an additional 155,235 shares during the quarter. Epoch Investment Partners Inc.’s holdings in Waters were worth $85,498,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also recently modified their holdings of WAT. IMPACTfolio LLC raised its position in Waters by 4.2% during the fourth quarter. IMPACTfolio LLC now owns 803 shares of the medical instruments supplier’s stock valued at $264,000 after acquiring an additional 32 shares in the last quarter. Mountain Pacific Investment Advisers Inc. ID raised its position in Waters by 0.3% during the fourth quarter. Mountain Pacific Investment Advisers Inc. ID now owns 11,469 shares of the medical instruments supplier’s stock valued at $3,776,000 after acquiring an additional 34 shares in the last quarter. Hohimer Wealth Management LLC raised its position in Waters by 2.7% during the fourth quarter. Hohimer Wealth Management LLC now owns 1,354 shares of the medical instruments supplier’s stock valued at $446,000 after acquiring an additional 35 shares in the last quarter. Tokio Marine Asset Management Co. Ltd. raised its position in Waters by 3.6% during the fourth quarter. Tokio Marine Asset Management Co. Ltd. now owns 1,413 shares of the medical instruments supplier’s stock valued at $465,000 after acquiring an additional 49 shares in the last quarter. Finally, Sequoia Financial Advisors LLC raised its position in Waters by 5.6% during the third quarter. Sequoia Financial Advisors LLC now owns 937 shares of the medical instruments supplier’s stock valued at $257,000 after acquiring an additional 50 shares in the last quarter. Institutional investors and hedge funds own 94.01% of the company’s stock.

Waters Trading Up 0.5 %

NYSE WAT traded up $1.54 on Friday, reaching $302.09. 453,576 shares of the company were exchanged, compared to its average volume of 518,595. The business’s fifty day moving average price is $327.55 and its 200 day moving average price is $322.57. The stock has a market capitalization of $17.92 billion, a P/E ratio of 29.65, a price-to-earnings-growth ratio of 4.79 and a beta of 0.97. The company has a current ratio of 1.94, a quick ratio of 1.30 and a debt-to-equity ratio of 1.60. Waters Co. has a fifty-two week low of $231.90 and a fifty-two week high of $367.21.

Waters (NYSE:WATGet Free Report) last announced its quarterly earnings results on Tuesday, May 7th. The medical instruments supplier reported $2.21 EPS for the quarter, beating the consensus estimate of $2.10 by $0.11. Waters had a return on equity of 66.59% and a net margin of 20.75%. The business had revenue of $636.80 million for the quarter, compared to analyst estimates of $635.57 million. During the same quarter in the prior year, the company posted $2.49 EPS. The company’s quarterly revenue was down 7.0% on a year-over-year basis. Analysts forecast that Waters Co. will post 11.85 earnings per share for the current year.

Insider Activity at Waters

In related news, Director Christopher A. Kuebler sold 4,000 shares of the business’s stock in a transaction on Wednesday, May 15th. The stock was sold at an average price of $361.64, for a total value of $1,446,560.00. Following the sale, the director now owns 14,716 shares in the company, valued at approximately $5,321,894.24. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In other Waters news, Director Linda Baddour sold 500 shares of the company’s stock in a transaction dated Wednesday, March 13th. The stock was sold at an average price of $355.54, for a total transaction of $177,770.00. Following the sale, the director now owns 2,250 shares in the company, valued at approximately $799,965. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Christopher A. Kuebler sold 4,000 shares of the company’s stock in a transaction dated Wednesday, May 15th. The stock was sold at an average price of $361.64, for a total value of $1,446,560.00. Following the sale, the director now owns 14,716 shares in the company, valued at approximately $5,321,894.24. The disclosure for this sale can be found here. Company insiders own 0.82% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on WAT shares. Stifel Nicolaus boosted their price objective on Waters from $330.00 to $332.00 and gave the company a “hold” rating in a research report on Wednesday, May 8th. TD Cowen boosted their price objective on Waters from $350.00 to $358.00 and gave the company a “hold” rating in a research report on Wednesday, May 8th. Jefferies Financial Group started coverage on Waters in a research report on Monday, June 3rd. They issued a “hold” rating and a $320.00 price objective for the company. Robert W. Baird cut their price objective on Waters from $319.00 to $312.00 and set a “neutral” rating for the company in a research report on Wednesday, May 8th. Finally, Barclays lowered their price target on Waters from $300.00 to $295.00 and set an “underweight” rating on the stock in a research note on Wednesday, May 8th. One equities research analyst has rated the stock with a sell rating and eleven have given a hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $307.20.

Check Out Our Latest Report on Waters

Waters Profile

(Free Report)

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Read More

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WATFree Report).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.